| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 0.0004 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.002 |